{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:43:58Z","timestamp":1792673038462,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10120-023-01366-5","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:02:31Z","timestamp":1674640951000},"page":"352-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9138-8930","authenticated-orcid":false,"given":"Hiroko","family":"Ideo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Inaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Minamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1366_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.20517\/2394-4722.2017.77","volume":"4","author":"Y Kiyozumi","year":"2018","unstructured":"Kiyozumi Y, Iwatsuki M, Yamashita K, Koga Y, Yoshida N, Baba H. Update on targeted therapy and immune therapy for gastric cancer, 2018. J Cancer Metastasis Treat. 2018;4:31.","journal-title":"J Cancer Metastasis Treat"},{"key":"1366_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12957-019-1761-y","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen JQ, Liu JL, Tian L. Issues on peritoneal metastasis of gastric cancer: an update. World J Surg Oncol. 2019;17:215.","journal-title":"World J Surg Oncol"},{"key":"1366_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms19030905","volume":"19","author":"RPM Dings","year":"2018","unstructured":"Dings RPM, Miller MC, Griffin RJ, Mayo KH. Galectins as molecular targets for therapeutic intervention. Int J Mol Sci. 2018;19:905.","journal-title":"Int J Mol Sci"},{"key":"1366_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13238-016-0262-9","volume":"7","author":"ZQ Cao","year":"2016","unstructured":"Cao ZQ, Guo XL. The role of galectin-4 in physiology and diseases. Protein Cell. 2016;7:314\u201324.","journal-title":"Protein Cell"},{"key":"1366_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/B:GLYC.0000025819.54723.a0","volume":"20","author":"ME Huflejt","year":"2004","unstructured":"Huflejt ME, Leffler H. Galectin-4 in normal tissues and cancer. Glycoconj J. 2004;20:247\u201355.","journal-title":"Glycoconj J"},{"key":"1366_CR6","first-page":"889","volume":"61","author":"Y Hippo","year":"2001","unstructured":"Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 2001;61:889\u201395.","journal-title":"Cancer Res"},{"key":"1366_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/ijc.29520","volume":"137","author":"H Ideo","year":"2015","unstructured":"Ideo H, Hinoda Y, Sakai K, Hoshi I, Yamamoto S, Oka M, et al. Expression of mucin 1 possessing a 3\u2019-sulfated core1 in recurrent and metastatic breast cancer. Int J Cancer. 2015;137:1652\u201360.","journal-title":"Int J Cancer"},{"key":"1366_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/glycob\/cwt073","volume":"23","author":"H Ideo","year":"2013","unstructured":"Ideo H, Hoshi I, Yamashita K, Sakamoto M. Phosphorylation and externalization of galectin-4 is controlled by Src family kinases. Glycobiology. 2013;23:1452\u201362.","journal-title":"Glycobiology"},{"key":"1366_CR9","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1158\/0008-5472.CAN-16-0641","volume":"76","author":"CH Tsai","year":"2016","unstructured":"Tsai CH, Tzeng SF, Chao TK, Tsai CY, Yang YC, Lee MT, et al. Metastatic progression of prostate cancer is mediated by autonomous binding of galectin-4-O-glycan to cancer cells. Cancer Res. 2016;76:5756\u201367.","journal-title":"Cancer Res"},{"key":"1366_CR10","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1073\/pnas.1505979112","volume":"112","author":"A Rotem","year":"2015","unstructured":"Rotem A, Janzer A, Izar B, Ji Z, Doench JG, Garraway LA, et al. Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Proc Natl Acad Sci U S A. 2015;112:5708\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1366_CR11","doi-asserted-by":"publisher","first-page":"14434","DOI":"10.1074\/jbc.M113.529578","volume":"289","author":"XW Li","year":"2014","unstructured":"Li XW, Rees JS, Xue P, Zhang H, Hamaia SW, Sanderson B, et al. New insights into the DT40 B cell receptor cluster using a proteomic proximity labeling assay. J Biol Chem. 2014;289:14434\u201347.","journal-title":"J Biol Chem"},{"key":"1366_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ijc.25750","volume":"129","author":"A Satelli","year":"2011","unstructured":"Satelli A, Rao PS, Thirumala S, Rao US. Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer. 2011;129:799\u2013809.","journal-title":"Int J Cancer"},{"key":"1366_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<612::AID-IJC20>3.0.CO;2-D","volume":"70","author":"T Nakashio","year":"1997","unstructured":"Nakashio T, Narita T, Akiyama S, Kasai Y, Kondo K, Ito K, et al. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Int J Cancer. 1997;70:612\u20138.","journal-title":"Int J Cancer"},{"key":"1366_CR14","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1002\/ijc.26330","volume":"130","author":"Y Toiyama","year":"2012","unstructured":"Toiyama Y, Yasuda H, Saigusa S, Matushita K, Fujikawa H, Tanaka K, et al. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor\/c-Met signaling in gastric cancer. Int J Cancer. 2012;130:2912\u201321.","journal-title":"Int J Cancer"},{"key":"1366_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1084\/jem.20181827","volume":"216","author":"NM Aiello","year":"2019","unstructured":"Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J Exp Med. 2019;216:1016\u201326.","journal-title":"J Exp Med"},{"key":"1366_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","volume":"49","author":"F Kai","year":"2019","unstructured":"Kai F, Drain AP, Weaver VM. The extracellular matrix modulates the metastatic journey. Dev Cell. 2019;49:332\u201346.","journal-title":"Dev Cell"},{"key":"1366_CR17","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1038\/onc.2009.139","volume":"28","author":"S Mori","year":"2009","unstructured":"Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, et al. Anchorage- independent cell growth signature identifies tumors with metastatic potential. Oncogene. 2009;28:2796\u2013805.","journal-title":"Oncogene"},{"key":"1366_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/cas.12301","volume":"104","author":"L Zhao","year":"2013","unstructured":"Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, et al. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Sci. 2013;104:1640\u20136.","journal-title":"Cancer Sci"},{"key":"1366_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081883","volume":"8","author":"T Hayashi","year":"2013","unstructured":"Hayashi T, Saito T, Fujimura T, Hara K, Takamochi K, Mitani K, et al. Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma. PLoS ONE. 2013;8: e81883.","journal-title":"PLoS ONE"},{"key":"1366_CR20","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.18632\/oncotarget.2104","volume":"5","author":"M Maftouh","year":"2014","unstructured":"Maftouh M, Belo AI, Avan A, Funel N, Peters GJ, Giovannetti E, et al. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt\/\u03b2-catenin signalling in pancreatic adenocarcinoma. Oncotarget. 2014;5:5335\u201349.","journal-title":"Oncotarget"},{"key":"1366_CR21","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/cas.12536","volume":"105","author":"Z Cai","year":"2014","unstructured":"Cai Z, Zeng Y, Xu B, Gao Y, Wang S, Zeng J, et al. Galectin-4 serves as a prognostic biomarker for the early recurrence \/ metastasis of hepatocellular carcinoma. Cancer Sci. 2014;105:1510\u20137.","journal-title":"Cancer Sci"},{"key":"1366_CR22","first-page":"10233","volume":"10","author":"C Chen","year":"2017","unstructured":"Chen C, Wang G, Huang X, Dong X, Chen G, Lin M, et al. Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo. Int J Clin Exp Pathol. 2017;10:10233\u201342.","journal-title":"Int J Clin Exp Pathol"},{"key":"1366_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/biomedicines9091159","volume":"9","author":"CH Li","year":"2021","unstructured":"Li CH, Chang YC, Chan MH, Yang YF, Liang SM, Hsiao M. Galectins in cancer and the microenvironment: functional roles, therapeutic developments, and perspectives. Biomedicines. 2021;9:1159.","journal-title":"Biomedicines"},{"key":"1366_CR24","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","volume":"22","author":"M Kanda","year":"2016","unstructured":"Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol. 2016;22:6829\u201340.","journal-title":"World J Gastroenterol"},{"key":"1366_CR25","first-page":"6991","volume":"14","author":"F Sun","year":"2017","unstructured":"Sun F, Feng M, Guan W. Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett. 2017;14:6991\u20138.","journal-title":"Oncol Lett"},{"key":"1366_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/bjc.2016.401","volume":"116","author":"H Kodama","year":"2017","unstructured":"Kodama H, Murata S, Ishida M, Yamamoto H, Yamaguchi T, Kaida S, et al. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer. Br J Cancer. 2017;116:186\u201394.","journal-title":"Br J Cancer"},{"key":"1366_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40291-021-00568-w","volume":"26","author":"Y Dong","year":"2022","unstructured":"Dong Y, Xu J, Sun B, Wang J, Wang Z. MET-targeted therapies and clinical outcomes: a systematic literature review. Mol Diagn Ther. 2022;26:203\u201327.","journal-title":"Mol Diagn Ther"},{"key":"1366_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","volume":"9","author":"H Xu","year":"2020","unstructured":"Xu H, Niu M, Yuan X, Wu K, Liu A. CD44 as a tumor biomarker and therapeutic target. Exp Hematol Oncol. 2020;9:36.","journal-title":"Exp Hematol Oncol"},{"key":"1366_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines3010046","volume":"3","author":"G Viticchi\u00e8","year":"2015","unstructured":"Viticchi\u00e8 G, Muller PAJ. c-Met and other cell surface molecules: interaction, activation and functional consequences. Biomedicines. 2015;3:46\u201370.","journal-title":"Biomedicines"},{"key":"1366_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fcell.2020.00490","volume":"8","author":"X Hu","year":"2020","unstructured":"Hu X, Tang F, Liu P, Zhong T, Yuan F, He Q, et al. Structural and functional insight into the glycosylation impact upon the HGF\/c-Met signaling pathway. Front Cell Dev Biol. 2020;8:490.","journal-title":"Front Cell Dev Biol"},{"key":"1366_CR31","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1111\/febs.16179","volume":"289","author":"Q Guo","year":"2022","unstructured":"Guo Q, Yang C, Gao F. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J. 2022;289:7970\u201386.","journal-title":"FEBS J"},{"key":"1366_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.neo.2018.06.001","volume":"20","author":"S Barkeer","year":"2018","unstructured":"Barkeer S, Chugh S, Batra SK, Ponnusamy MP. Glycosylation of cancer stem cells: function in stemness, tumorigenesis, and metastasis. Neoplasia. 2018;20:813\u201325.","journal-title":"Neoplasia"},{"key":"1366_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cell.2005.09.041","volume":"123","author":"K Ohtsubo","year":"2005","unstructured":"Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell. 2005;123:1307\u201321.","journal-title":"Cell"},{"key":"1366_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.acthis.2010.02.004","volume":"113","author":"H Ghazarian","year":"2011","unstructured":"Ghazarian H, Idoni B, Oppenheimer SB. A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem. 2011;113:236\u201347.","journal-title":"Acta Histochem"},{"key":"1366_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540\u201355.","journal-title":"Nat Rev Cancer"},{"key":"1366_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1083\/jcb.200407073","volume":"69","author":"D Delacour","year":"2005","unstructured":"Delacour D, Gouyer V, Zanetta JP, Drobecq H, Leteurtre E, Grard G, et al. Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J Cell Biol. 2005;69:491\u2013501.","journal-title":"J Cell Biol"},{"key":"1366_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1600-0854.2009.00882.x","volume":"10","author":"L Stechly","year":"2009","unstructured":"Stechly L, Morelle W, Dessein AF, Andr\u00e9 S, Grard G, Trinel D, et al. Galectin-4-regulated delivery of glycoproteins to the brush border membrane of enterocyte-like cells. Traffic. 2009;10:438\u201350.","journal-title":"Traffic"},{"key":"1366_CR38","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1074\/jbc.M410362200","volume":"280","author":"H Ideo","year":"2005","unstructured":"Ideo H, Seko A, Yamashita K. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem. 2005;280:4730\u20137.","journal-title":"J Biol Chem"},{"key":"1366_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12253-013-9650-0","volume":"19","author":"J Ma","year":"2013","unstructured":"Ma J, Ma J, Meng Q, Zhao ZS, Xu WJ. Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma. Pathol Oncol Res. 2013;19:821\u201332.","journal-title":"Pathol Oncol Res"},{"key":"1366_CR40","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-11-1462","volume":"17","author":"H Barrow","year":"2011","unstructured":"Barrow H, Guo X, Wandall HH, Pedersen JW, Fu B, et al. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res. 2011;17:7035\u201346.","journal-title":"Clin Cancer Res"},{"key":"1366_CR41","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.21474\/IJAR01\/3269","volume":"5","author":"AH Arnaout","year":"2017","unstructured":"Arnaout AH, Ibrahim LM. Serum galectin-4 (gal-4) in patients with gastric adenocarcinoma: active player in the field. Int J Adv Res. 2017;5:1162\u20137.","journal-title":"Int J Adv Res"},{"key":"1366_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","volume":"313","author":"AU Newlaczyl","year":"2011","unstructured":"Newlaczyl AU, Yu LG. Galectin-3\u2013a jack-of-all-trades in cancer. Cancer Lett. 2011;313:123\u20138.","journal-title":"Cancer Lett"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-023-01366-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T01:09:46Z","timestamp":1706144986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-023-01366-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s10120-023-01366-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"31 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed in this study. The Kanazawa University Human Genome and Gene Analysis Research Ethics Committee (Project No. 181) and the Noguchi Institute Research Ethics Committee (Project No. 2201) approved the design and protocols for studying the gastric cancer patients with peritoneal metastasis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}